Medifar SA
0.7 FTEMedifar reported total assets of 921,854 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026), with 0.7 full-time equivalent.
The score of Medifar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets +9 % Headcount (avg FTE) -30 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medifar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 115,474 € | ||||
| Equity | 869,111 € | ||||
| Cash | 333,678 € | ||||
| EBITDA | 212,408 € | ||||
| Total assets | 921,854 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Medifar's financial analysis
- Solvency94.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medifar
Medifar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.978.480
- VAT number
- BE0456978480
- Peppol
- Registered · 0208:0456978480 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Jan 1996
- Registered office
- 2450 Meerhout
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medifar (SA) has been based in Meerhout since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 115,474 € and equity of 869,111 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 94.3%, above the median of its sector (44.2%).
Companies similar to Medifar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Soetkin Op De Beeck Retail sale of pharmaceutical products Blankenberge · balance sheet 916,196 €
- Pharmacie Pierrot Retail sale of pharmaceutical products Mons · balance sheet 956,937 €
- Europa Apotheek Retail sale of pharmaceutical products Antwerp · balance sheet 819,025 €
- Piers Retail sale of pharmaceutical products Ostend · balance sheet €1.05m
- Pharmaplus Detimmerman Retail sale of pharmaceutical products Tournai · balance sheet 803,004 €
- Farmacie Céline Desmet Retail sale of pharmaceutical products Heuvelland · balance sheet €1.06m
- Paques Pharma Retail sale of pharmaceutical products Profondeville · balance sheet 797,673 €
- Geassocieerde Apotheek Piot Retail sale of pharmaceutical products Antwerp · balance sheet 784,378 €
Frequently asked questions about Medifar
What is the revenue of Medifar?
Medifar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medifar?
In Belgium, the VAT number is the company number prefixed with BE: BE0456978480 for Medifar, if the company is VAT-registered. Its company number (CBE) is 0456.978.480.
Where is the registered office of Medifar?
According to the CBE register, the registered office of Medifar is in 2450 Meerhout.
What is the equity of Medifar?
At the close of the 2025 financial year, the equity of Medifar amounts to 869,111 €, a solvency of 94.3% of total assets.
How many people work at Medifar?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medifar?
The register lists 7 active mandates at Medifar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medifar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →